The U.S. Food and Drug Administration expanded approval for Johnson & Johnsons nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the com… [read more]
FDA approves standalone use of J&J’s ketamine-derived depression treatment – CNN
You Might Also Like
/cdn.vox-cdn.com/uploads/chorus_asset/file/13695430/acastro_190116_3172_AI_Larping_0001.0.jpg)
Big Tech is already warning us about AI privacy problems – The Verge
Major delays at Newark Airport roll into fifth day as FAA cites air traffic control staffing issues – CNN
